Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toripalimab”

419 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 419 results

Testing effectiveness (Phase 2)Looking for participantsNCT05147844
What this trial is testing

Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Xinqiao Hospital of Chongqing 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07189793
What this trial is testing

Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma, Transitional CellCarcinoma in Situ of Bladder+1 more
First Affiliated Hospital of Wenzhou Medical University 106
Large-scale testing (Phase 3)UnknownNCT03924050
What this trial is testing

Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 440
Testing effectiveness (Phase 2)Active Not RecruitingNCT06419673
What this trial is testing

Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer

Who this might be right for
Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 240
Testing effectiveness (Phase 2)UnknownNCT04170179
What this trial is testing

Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 25
Early research (Phase 1)Study completedNCT05040932
What this trial is testing

Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy

Who this might be right for
Cancer
Eucure (Beijing) Biopharma Co., Ltd 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05484375
What this trial is testing

Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment

Who this might be right for
Metastatic Nasopharyngeal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06509009
What this trial is testing

Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma by AJCC V8 Stage
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Large-scale testing (Phase 3)Looking for participantsNCT06170489
What this trial is testing

A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)

Who this might be right for
Hodgkin Lymphoma
Shanghai Junshi Bioscience Co., Ltd. 185
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07244874
What this trial is testing

Sac-TMT Combined With Toripalimab for First-line Treatment of PD-L1 Positive a/mTNBC

Who this might be right for
TNBC - Triple-Negative Breast CancerPD-L1 Positive
Tianjin Medical University Cancer Institute and Hospital 41
Testing effectiveness (Phase 2)Study completedNCT04005170
What this trial is testing

Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Unresectable Esophageal Cancer
Mian XI 42
Large-scale testing (Phase 3)Study completedNCT03829969
What this trial is testing

Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell Carcinoma

Who this might be right for
Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy
Shanghai Junshi Bioscience Co., Ltd. 514
Testing effectiveness (Phase 2)UnknownNCT04316351
What this trial is testing

Efficacy and Safety of Toripalimab (JS001) Combined With Pemetrexed and Anlotinib for Patients With T790M Positive Non-Small Cell Lung Cancer After Osimertinib Resistance

Who this might be right for
IIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib Therapy
Guangzhou Institute of Respiratory Disease 60
Large-scale testing (Phase 3)Looking for participantsNCT05342194
What this trial is testing

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Junshi Bioscience Co., Ltd. 480
Testing effectiveness (Phase 2)UnknownNCT03941795
What this trial is testing

Phase II Study in the Treatment of Patients With Advanced Mucinous Melanoma

Who this might be right for
Advanced Mucosal Melanoma
Peking University Cancer Hospital & Institute 99
Large-scale testing (Phase 3)Looking for participantsNCT06095583
What this trial is testing

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Shanghai Junshi Bioscience Co., Ltd. 756
Testing effectiveness (Phase 2)Looking for participantsNCT06354231
What this trial is testing

DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC

Who this might be right for
Renal InsufficiencyUpper Urinary Tract Urothelial CarcinomaSolitary Kidney
Fudan University 20
Early research (Phase 1)WithdrawnNCT05262842
What this trial is testing

JS001+IMP4297 in Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Shanghai Junshi Bioscience Co., Ltd.
Testing effectiveness (Phase 2)UnknownNCT04025931
What this trial is testing

Chidamide Combined With Toripalimab in Sarcoma

Who this might be right for
Sarcoma
Sun Yat-sen University 74
Testing effectiveness (Phase 2)Ended earlyNCT04418648
What this trial is testing

Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

Who this might be right for
Small Cell Lung Cancer Limited Stage
Sun Yat-sen University 170
Load More Results